- Previous Close
13,190.00 - Open
13,150.00 - Bid 13,180.00 x --
- Ask 13,190.00 x --
- Day's Range
12,920.00 - 13,200.00 - 52 Week Range
10,420.00 - 17,500.00 - Volume
26,490 - Avg. Volume
32,794 - Market Cap (intraday)
169.228B - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield 200.00 (1.52%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
Gradiant Corporation, together with its subsidiaries, engages in e-commerce business in South Korea, Vietnam, China, and internationally. It operates through Holding Business; Industrial B2B E-Commerce Business; Bio Healthcare Business; and Other Business segments. The company focuses on life sciences and healthcare, environment and energy, and creative learning platform businesses. It offers EV charging, organoids, venture capital funding for the biotech sector, advertising, and logistics agency services, as well as an online creative learning platform. The company also procures and distributes pharmaceutical drugs and medical supplies to hospitals; develops oncology drugs; develops, manufactures, and commercializes adhesive films for electronic devices, such as smartphones; and supplies MRO and industrial consumables goods through the internet. In addition, it is involved in investing, consulting, and freight transportation brokerage and agency activities. The company was formerly known as Interpark Co., Ltd. and changed its name to Gradiant Corporation in February 2022. Gradiant Corporation was founded in 1995 and is headquartered in Seoul, South Korea.
www.gradiant.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 035080.KQ
View MorePerformance Overview: 035080.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 035080.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 035080.KQ
View MoreValuation Measures
Market Cap
169.23B
Enterprise Value
-12.98B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.05
Price/Book (mrq)
0.34
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.22%
Return on Assets (ttm)
-0.19%
Return on Equity (ttm)
-3.20%
Revenue (ttm)
3.32T
Net Income Avi to Common (ttm)
-40.38B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
362.3B
Total Debt/Equity (mrq)
22.96%
Levered Free Cash Flow (ttm)
-20.39B